PATENT CLAIM ANALYSIS

Application Number: 15936927
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "023000"]

Abstract:
The invention relates to the treatment or prevention of renal impairment and/or complications using a SGLT-2 inhibitor, for example in patients diagnosed with metabolic disorders and related conditions.

Claim (Index 1):
Method for preventing, slowing the progression of, delaying or treating renal hyperfiltrative injury in a patient in need thereof characterized in that a pharmaceutical composition comprising an SGLT2 inhibitor is administered to the patient, wherein the SGLT2 inhibitor is 1-chloro-4-(\u03b2-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene or a prodrug thereof.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 90.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13912599', '12673327', '13511771', '14048880', '12894385']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7547443825408278
- 35 USC 102 Novelty (BERT): 0.5273806918231136
- Combined Prediction Score: 0.7320080134690564
- Mean Citation Score: 319.601472
- Max Citation Score: 352.47964
- Similarity Product: 268.63145007103924

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test